RXi Pharmaceuticals Corporation (RXII) climbed 11.89% or 0.51 to $4.8. It is near to 263351 shares traded, which is 562.54% compare to the average total volume 46815. The market cap of RXII is $1.14 million. The year to date change is -22.0%. The 52 week price range is from $3.2 to $11.2. Price of RXII have changed -4.88% during last week. It have changed -31.90% over last month, -14.20% over last 3 months, -36.91% over last 6 months and -42.54% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RXII is 5.70. It is 18.75% above current price. The 200-day Moving Averages for RXII is 5.92. It is 23.33% above current price. The 52-week High is 11.2. It is 133.33% from the current price. The 52-week Low is 3.2. It is -33.33% from current price.
There are some statistics of RXII. It is has market cap $1.14 million. The share outstanding is 236973. The average volume is 46815. The percent of top 15 Institution holding is 3.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RXII is -459.76%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RXII is -271.89%.